Upgrade to SI Premium - Free Trial

Theravance Biopharma (TBPH) PT Lowered to $14 at BofA Securities

August 24, 2021 5:21 AM
BofA Securities analyst Tazeen Ahmad ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles